Q4 FY24 Quarterly Investor Presentation & Webinar
Filed with ASX · · 41 pages · English
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings CallMicroba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is pleased to provide below its Q4 FY24 Investor Presentation and Investor Webinar with CEO Dr Luke Reid and SVP, Therapeutics Prof. Trent Munro presenting. Presenting: CEO, Dr Luke Reid and SVP, Therapeutics Prof. Trent Munro Webinar Access: The Quarterly Investor Presentation Webinar can now be accessed on demand via Microba’s
Microba Life Sciences Limited on 6ix
In the deck
Story so far
Earlier from Microba Life Sciences
- Q4 FY24 Quarterly Activities Report & Appendix 4C
- Completion of Autoimmune Program with Ginkgo Bioworks
- Q3 FY24 Quarterly Investor Presentation
- Q3 FY24 Quarterly Activities Report & Appendix 4C
- Microba receives $6.08 million R&D Tax Incentive Refund
Later from Microba Life Sciences
- 2024 Annual Report & Appendix 4E
- Q1 FY25 Quarterly Activities Report & Appendix 4C
- Q1 FY25 Quarterly Investor Presentation
- Microba receives $6 million R&D Tax Incentive Refund
- Trading Update
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences